CRISPR Therapeutics
CRSP
#3489
Rank
C$3.98 B
Marketcap
$46.40
Share price
-0.03%
Change (1 day)
-46.88%
Change (1 year)

Market capitalization of CRISPR Therapeutics (CRSP)

Market cap: C$3.98 Billion

As of April 2025 CRISPR Therapeutics has a market cap of C$3.98 Billion. This makes CRISPR Therapeutics the world's 3489th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CRISPR Therapeutics from 2016 to 2025

End of year Market Cap

Year Marketcap Change
2025C$3.98 B-18.8%
2024C$4.90 B-25.68%
2023C$6.59 B52.71%
2022C$4.31 B-41.57%
2021C$7.39 B-46.83%
2020C$13.90 B187.51%
2019C$4.83 B139.6%
2018C$2.01 B69.82%
2017C$1.18 B9.64%
2016C$1.08 B

End of Day market cap according to different sources

On Apr 3rd, 2025 the market cap of CRISPR Therapeutics was reported to be:

C$3.98 Billion
by Nasdaq info icon info icon
C$3.98 Billion
by CompaniesMarketCap info icon info icon
C$3.98 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$0.49 B-87.62%๐Ÿ‡บ๐Ÿ‡ธ USA